Company A.P. Pharma, Inc. Other OTC
Equities
US00202J2033
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Innovations
100.0
%
| 108 | 100.0 % | 127 | 100.0 % | +17.99% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 108 | 100.0 % | 127 | 100.0 % | +17.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/23/21 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16/23/16 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/18/01 |
Chief Tech/Sci/R&D Officer | 65 | 30/12/30 | |
John C. Arthur
PRN | Corporate Officer/Principal | 58 | 01/17/01 |
Sean T. Ristine
HRO | Human Resources Officer | 54 | 01/14/01 |
William Forbes
PRN | Corporate Officer/Principal | 62 | 06/23/06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/23/21 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20/21/20 |
Craig Johnson
BRD | Director/Board Member | 62 | 13/14/13 |
Christian Waage
BRD | Director/Board Member | 57 | 22/16/22 |
Adam Morgan
CHM | Chairman | 45 | 21/23/21 |
Director/Board Member | 49 | 20/21/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 150,653,158 | 149,597,060 ( 99.30 %) | 0 | 99.30 % |
Company contact information
Heron Therapeutics, Inc.
4242 Campus Point Court Suite 200
92121, San Diego
+858 251 4400
http://www.herontx.comSector
1st Jan change | Capi. | |
---|---|---|
+18.97% | 4.53TCr | |
+41.98% | 4.04TCr | |
-10.06% | 3.79TCr | |
+31.15% | 3.18TCr | |
-7.79% | 2.77TCr | |
+13.32% | 2.65TCr | |
+43.05% | 1.4TCr | |
+31.28% | 1.24TCr | |
-7.41% | 1.13TCr |
- Stock Market
- Equities
- HRTX Stock
- Stock
- Company A.P. Pharma, Inc.